Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0B6TW
|
|||
Drug Name |
Leucovorin Calcium
|
|||
Synonyms |
Leucovorin Calcium Preservative Free; Wellcovorin
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Approved | [1] | |
Therapeutic Class |
Anticancer Agents
|
|||
Company |
Hospira Inc
|
|||
Structure |
Download2D MOL
|
|||
Formula |
C20H21CaN7O7
|
|||
Canonical SMILES |
C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)[O-])C(=O)[O-].[Ca+2]
|
|||
InChI |
1S/C20H23N7O7.Ca/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30;/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32);/q;+2/p-2/t12?,13-;/m0./s1
|
|||
InChIKey |
KVUAALJSMIVURS-ZEDZUCNESA-L
|
|||
CAS Number |
CAS 1492-18-8
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:31340
|
|||
ADReCS Drug ID | BADD_D01259 |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Dihydrofolate reductase (DHFR) | Target Info | Modulator | [2] |
KEGG Pathway | One carbon pool by folate | |||
Folate biosynthesis | ||||
Metabolic pathways | ||||
Panther Pathway | Tetrahydrofolate biosynthesis | |||
Formyltetrahydroformate biosynthesis | ||||
Pathwhiz Pathway | Folate Metabolism | |||
Pterine Biosynthesis | ||||
Pathway Interaction Database | E2F transcription factor network | |||
Reactome | E2F mediated regulation of DNA replication | |||
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | ||||
Metabolism of folate and pterines | ||||
G1/S-Specific Transcription | ||||
WikiPathways | Nucleotide Metabolism | |||
Trans-sulfuration and one carbon metabolism | ||||
Retinoblastoma (RB) in Cancer | ||||
One Carbon Metabolism | ||||
Metabolism of water-soluble vitamins and cofactors | ||||
Metabolism of nitric oxide | ||||
Folate Metabolism | ||||
Fluoropyrimidine Activity |
References | Top | |||
---|---|---|---|---|
REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
REF 2 | Biochemical factors in the selectivity of leucovorin rescue: selective inhibition of leucovorin reactivation of dihydrofolate reductase and leucovorin utilization in purine and pyrimidine biosynthesis by methotrexate and dihydrofolate polyglutamates.NCI Monogr.1987;(5):17-26. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.